Tepavcevic D, Giljevic Z, Korsic M, Halimi S, Suchanek E, Jelic T
J Endocrinol Invest. 1994; 17(1):1-5.
PMID: 8006323
DOI: 10.1007/BF03344953.
Tepavcevic D, Giljevic Z, Aganovic I, Korsic M, Halimi S, Suchanek E
J Endocrinol Invest. 1995; 18(6):427-30.
PMID: 7594236
DOI: 10.1007/BF03349740.
Lilavivat U, Brodows R, Campbell R
Diabetologia. 1981; 20(4):482-8.
PMID: 7016643
DOI: 10.1007/BF00253412.
DROST H, GRUNEKLEE D, Kley H, Wiegelmann W, KRUSKEMPER H, Gries F
Klin Wochenschr. 1980; 58(21):1197-205.
PMID: 7005532
DOI: 10.1007/BF01478876.
Pezzarossa A, Coiro V, BUTTURINI U
Acta Diabetol Lat. 1982; 19(3):219-26.
PMID: 6756004
DOI: 10.1007/BF02624681.
Development of Cushing's disease in a patient with anorexia nervosa.
Kontula K, Mustajoki P, Paetau A, PELKONEN R
J Endocrinol Invest. 1984; 7(1):35-40.
PMID: 6715794
DOI: 10.1007/BF03348373.
Neuroendocrine effects of quipazine in man in health state or with neurological disorders.
Parati E, Zanardi P, Cocchi D, Caraceni T, Muller E
J Neural Transm. 1980; 47(4):273-97.
PMID: 6446595
DOI: 10.1007/BF01247322.
Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis.
Laakmann G, Wittmann M, Gugath M, Mueller O, Treusch J, Wahlster U
Psychopharmacology (Berl). 1984; 84(1):66-70.
PMID: 6093182
DOI: 10.1007/BF00432027.
Antiserotonergic inhibition of calcitonin-induced increase of beta-endorphin, ACTH, and cortisol secretion.
LAURIAN L, OBERMAN Z, Hoerer E, Graf E
J Neural Transm. 1988; 73(3):167-76.
PMID: 2850348
DOI: 10.1007/BF01250134.
Cushing's disease: failure of treatment with cyproheptadine.
Allgrove J, Husband P, Brook C
Br Med J. 1977; 1(6062):686-7.
PMID: 843872
PMC: 1605565.
DOI: 10.1136/bmj.1.6062.686-a.
Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran).
Joost H, Beckmann J, Holze S, Lenzen S, Poser W, HASSELBLATT A
Diabetologia. 1976; 12(3):201-6.
PMID: 782991
DOI: 10.1007/BF00422086.
Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
Harrower A, Yap P, Nairn I, Walton H, Strong J, Craig A
Br Med J. 1977; 2(6080):156-9.
PMID: 577473
PMC: 1631096.
DOI: 10.1136/bmj.2.6080.156.
Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.
Ferrari C, Barbieri C, Caldara R, Magnoni V, Testori G, ROMUSSI M
Eur J Clin Pharmacol. 1979; 15(6):395-9.
PMID: 499287
DOI: 10.1007/BF00561737.
Hormonal responses to insulin infusion in diabetes mellitus.
Campbell L, Kraegen E, Meler H, Lazarus L
Diabetologia. 1979; 16(6):359-64.
PMID: 467845
DOI: 10.1007/BF01223155.
Anterior pituitary function in women with postpartum hemorrhage.
Kayne R, Burrow G
Yale J Biol Med. 1978; 51(2):143-50.
PMID: 308279
PMC: 2595674.
Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep.
Chihara K, Kato Y, Maeda K, Matsukura S, Imura H
J Clin Invest. 1976; 57(6):1393-402.
PMID: 180050
PMC: 436797.
DOI: 10.1172/JCI108408.
